投稿信息
投稿信息
審稿費(fèi)用
暫無數(shù)據(jù)
版面費(fèi)用
暫無數(shù)據(jù)
中國人發(fā)表比例
2023年中國人文章占該期刊總數(shù)量16.67% (2022年為9.09%)
自引率
3.3 %
年文章數(shù)
448
期刊官網(wǎng)
點(diǎn)擊查看
(點(diǎn)擊次數(shù):6888)
投稿鏈接
點(diǎn)擊查看
(點(diǎn)擊次數(shù):2298次)
作者需知
暫無數(shù)據(jù)
NCBI查詢
偏重的研究方向
期刊簡介
稿件收錄要求
稿件收錄要求
Published by Adis International Limited (now part of Wolters Kluwer Health).
ISSN: 1177-1062.
Combining the cutting-edge content of Molecular Diagnosis and the American Journal of Pharmacogenomics, Molecular Diagnosis & Therapy brings you independent and authoritative insights into the latest molecular diagnostic and pharmacogenomic techniques to improve the diagnosis and treatment of disease in patients in an individualized manner. The combined journal provides more comprehensive insight into: Using biomarkers to guide drug development, serve as diagnostics, and target medicines toward specific populations; Detection, monitoring and treatment of the molecular causes of disease; Molecular markers and genetic variation affecting drug response, drug metabolism, adverse effects and/or disease progression; Molecular disease classification; Drug/diagnostic combinations (theranostics); Emerging molecular diagnostic tools and technologies; Pathogen detection and drug resistance analysis; Ethical and regulatory issues relating to personalized medicine.
Combining the cutting-edge content of Molecular Diagnosis and the American Journal of Pharmacogenomics, Molecular Diagnosis & Therapy brings you independent and authoritative insights into the latest molecular diagnostic and pharmacogenomic techniques to improve the diagnosis and treatment of disease in patients in an individualized manner. The combined journal provides more comprehensive insight into: Using biomarkers to guide drug development, serve as diagnostics, and target medicines toward specific populations; Detection, monitoring and treatment of the molecular causes of disease; Molecular markers and genetic variation affecting drug response, drug metabolism, adverse effects and/or disease progression; Molecular disease classification; Drug/diagnostic combinations (theranostics); Emerging molecular diagnostic tools and technologies; Pathogen detection and drug resistance analysis; Ethical and regulatory issues relating to personalized medicine.
常用鏈接
期刊論壇
|
中國SCI論文
|
期刊介紹
|
投稿信息
|
雜志官網(wǎng)
|
投稿鏈接
|
作者需知
|
PMC鏈接
|
Pubmed全文檢索
